301 related articles for article (PubMed ID: 28661679)
1. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms.
Li J; Wang X; Li C; Fan N; Wang J; He Z; Sun J
Mol Pharm; 2017 Aug; 14(8):2781-2792. PubMed ID: 28661679
[TBL] [Abstract][Full Text] [Related]
2. Surface Tracking of Curcumin Amorphous Solid Dispersions Formulated by Binary Polymers.
Fan N; Lu T; Li J
J Pharm Sci; 2020 Feb; 109(2):1068-1078. PubMed ID: 31639390
[TBL] [Abstract][Full Text] [Related]
3. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
Meng F; Trivino A; Prasad D; Chauhan H
Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
[TBL] [Abstract][Full Text] [Related]
4. Curcumin amorphous solid dispersions benefit from hydroxypropyl methylcellulose E50 to perform enhanced anti-inflammatory effects.
Zhang J; Shi X; Tao W
Int J Biol Macromol; 2023 Dec; 252():126507. PubMed ID: 37633564
[TBL] [Abstract][Full Text] [Related]
5. [Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].
Liang Q; Wang YR; Deng YY
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(15):3305-3311. PubMed ID: 31602887
[TBL] [Abstract][Full Text] [Related]
6. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
[TBL] [Abstract][Full Text] [Related]
7. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Li J; Li J
J Pharm Pharmacol; 2021 Mar; 73(2):185-192. PubMed ID: 33793808
[TBL] [Abstract][Full Text] [Related]
8. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
9. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
[TBL] [Abstract][Full Text] [Related]
10. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
11. Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions.
Chavan RB; Lodagekar A; Shastri NR
Drug Dev Ind Pharm; 2018 Dec; 44(12):1933-1941. PubMed ID: 30102080
[TBL] [Abstract][Full Text] [Related]
12. Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin.
Alves TFR; das Neves Lopes FCC; Rebelo MA; Souza JF; da Silva Pontes K; Santos C; Severino P; Junior JMO; Komatsu D; Chaud MV
Recent Pat Drug Deliv Formul; 2018; 12(1):65-74. PubMed ID: 29345599
[TBL] [Abstract][Full Text] [Related]
13. Impact of HPMC on inhibiting crystallization and improving permeability of curcumin amorphous solid dispersions.
Fan N; He Z; Ma P; Wang X; Li C; Sun J; Sun Y; Li J
Carbohydr Polym; 2018 Feb; 181():543-550. PubMed ID: 29254005
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Enhanced Nifedipine Dissolution by Polymer-Blended Solid Dispersion through Molecular-Level Characterization.
Ueda K; Yamazoe C; Yasuda Y; Higashi K; Kawakami K; Moribe K
Mol Pharm; 2018 Sep; 15(9):4099-4109. PubMed ID: 30064220
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
16. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
Baghel S; Cathcart H; O'Reilly NJ
Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
[TBL] [Abstract][Full Text] [Related]
17. Tailoring supersaturation from amorphous solid dispersions.
Li N; Taylor LS
J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
[TBL] [Abstract][Full Text] [Related]
18. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
19. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
Li B; Konecke S; Wegiel LA; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Oct; 98(1):1108-16. PubMed ID: 23987452
[TBL] [Abstract][Full Text] [Related]
20. Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions.
Liu L; Chen L; Müllers W; Serno P; Qian F
Mol Pharm; 2022 Aug; 19(8):2888-2899. PubMed ID: 35759395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
